Response to “Clarification on MTHFR Variants and Ischemic Stroke Risk”

Abstract

Keywords

stroke cerebrovascular disorders peripheral neuropathy hyperhomocysteinemia nitrous oxide MTHFR

Get full access to this article

View all access options for this article.

References

Robin

Meola

Munio

Gollion

Fabry

. Recurrent stroke and peripheral neuropathy associated with multifactorial hyperhomocysteinemia: a case report. Neurohospitalist. 2026;16:207-210.

Amarenco

Bogousslavsky

Caplan

Donnan

Wolf

Hennerici

. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1-5.

Daghlas

Wang

Gill

. Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations. Thromb J. 2025;23(1):1-5.

Bostom

Rosenberg

Silbershatz

, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999;131(5):352-355.

Parnetti

Caso

Santucci

, et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci. 2004;25(1):13-17.

Meschia

Bushnell

Boden-Albala

, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832.